Dec 17, 2004
What do you know about R278474?
Has it been presented at any conferences? Why has the media made such a big deal about it?
| Response from Dr. Henry
R278474 (also known as DAPYs) is a new compound developed at Rutgers University which inhibitors HIV reverse transciptase. Pre-clinical studies have been positive and I believe the first human studies are being planned. I have not seen in human/clinical data so I cannot comment further. KH
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Can Hiv Lay Dormant In A Woman For Up To Ten Years?
- Will Chlamydia Cause An Abnormal Pap Smear?
- What Percentage Of People With Hpv Get Genital Warts?
- What Is The Causative Agent Of Shingles?
- What Happens If Bacterial Vaginosis Is Not Treated?
- What Do Genital Warts Look Like In The Vagina?
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.